13F Holdings
中文EN

COCH Envoy Medical, Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1840877 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.1%
TTM net income YoY4.3%
TTM EPS YoY164.4%
Revenue 3-yr CAGR-1.4%
Net income 3-yr CAGR—

Margins

Gross margin-352.8%
Operating margin-10,151.5%
Net margin-9,026.4%
FCF margin—
EBITDA margin-10,020.8%

Returns

ROE—
ROA-152.5%
ROIC (approx.)—
Asset turnover0.02x

Leverage & solvency

Liabilities / assets106.0%
Debt / equity—
Current ratio1.21x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.07x
Accruals ratio10.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$241,000$225,000$316,000$237,000—
Cost of revenue$874,000$742,000$789,000$498,000—
Gross profit-$633,000-$517,000-$473,000-$261,000—
R&D expense$12.49M$10.18M$8.96M$4.97M—
SG&A expense$7.93M$6.83M$7.26M$2.58M—
Operating income-$22.27M-$19.26M-$18.36M-$8.71M-$5.20M
Interest expense$1.59M$816,000———
Pretax income-$23.76M-$20.80M—$20.74M-$251,633
Income tax———$1.50M—
Net income-$23.76M-$20.80M-$29.92M-$15.92M-$251,633
EBITDA-$21.97M-$19.08M-$18.23M-$8.63M—
EPS (basic)-1.23-1.49-2.54-1.57—
EPS (diluted)-1.23-1.49-2.54-1.57—
Weighted avg. shares (diluted)23.26M18.79M12.30M10.12M—
Balance sheet
Cash & equivalents$3.74M$5.48M$4.22M$183,000$1.12M
Receivables$34,000$38,000$70,000$41,000—
Inventory$1.55M$1.71M$1.40M$1.29M—
Current assets$6.28M$8.90M$7.46M$1.65M$863,167
PP&E, net$1.03M$1.27M$351,000$331,000—
Total assets$8.56M$11.54M$8.27M$2.56M$426.90M
Current liabilities$11.56M$7.54M$7.29M$2.52M$2.68M
Total liabilities$20.32M$30.38M$10.05M$38.75M$38.62M
Shareholders' equity-$12.16M-$18.84M-$1.78M-$36.20M-$44.96M
Shares outstanding—21.33M18.60M——
Cash flow statement
Operating cash flow-$18.20M-$17.95M-$17.09M-$8.80M-$3.24M
Capital expenditure$179,000$980,000$153,000$218,000—
Free cash flow-$18.38M-$18.93M-$17.24M-$9.02M—
Investing cash flow-$179,000-$980,000-$153,000-$218,000-$425.00M
Financing cash flow$16.63M$20.20M$21.28M$8.09M$428.37M
Depreciation & amortization$302,000$173,000$133,000$75,000—
Stock-based compensation$657,000$562,000$1.57M$0—
Dividends paid$1.82M$2.45M———

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.